Specific BARD1 isoforms are linked to cancer; for example, BARD1β is associated with neuroblastoma susceptibility, while BARD1δ, an isoform with a deletion, is linked to tumor progression and genomic instability. This evidence concerns the gene BARD1 and cancer.